title: [Fulminant hepatocellular necrosis following administration of docetaxel].
authors.forename: E
authors.initials: E
authors.lastname: Tomassini
authors.forename: J
authors.initials: J
authors.lastname: Muhizi
authors.forename: K
authors.initials: K
authors.lastname: al Raheb
authors.forename: G
authors.initials: G
authors.lastname: Steinbach
authors.forename: M
authors.initials: M
authors.lastname: Bemer
authors.forename: C
authors.initials: C
authors.lastname: Platini
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D000077143:Docetaxel; D005260:Female; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D009336:Necrosis; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel